TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 92 filers reported holding TANGO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,262 | -45.5% | 4,116,949 | 0.0% | 1.07% | -46.4% |
| Q4 2022 | $29,848 | -99.8% | 4,116,949 | 0.0% | 2.00% | +91.7% |
| Q3 2022 | $14,903,000 | -27.0% | 4,116,949 | -8.7% | 1.04% | -32.5% |
| Q2 2022 | $20,421,000 | -45.0% | 4,507,843 | -8.0% | 1.54% | -45.8% |
| Q1 2022 | $37,136,000 | -30.1% | 4,899,185 | 0.0% | 2.85% | -9.8% |
| Q4 2021 | $53,149,000 | +8.9% | 4,899,185 | +25.6% | 3.16% | +59.4% |
| Q3 2021 | $48,814,000 | – | 3,899,185 | – | 1.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $87,719,000 | 57.68% |
| TCG Crossover Management, LLC | 1,172,250 | $5,310,000 | 2.26% |
| Boxer Capital, LLC | 6,871,642 | $31,129,000 | 1.97% |
| Cormorant Asset Management, LP | 4,507,843 | $20,421,000 | 1.54% |
| Casdin Capital, LLC | 3,500,000 | $15,855,000 | 1.34% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $8,706,000 | 1.02% |
| Samsara BioCapital, LLC | 630,000 | $2,854,000 | 0.76% |
| Southpoint Capital Advisors LP | 4,500,000 | $20,385,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 708,385 | $3,209,000 | 0.37% |
| EcoR1 Capital, LLC | 2,302,065 | $10,428,000 | 0.36% |